PAREXEL Enters Alliance with ASAN Medical Center

The alliance offers regional and international sponsors with access to quality clinical trial services throughout Asia.

PAREXEL International Corp., a leading global biopharmaceutical services provider, announced yesterday that it has entered into an agreement with Seoul-based ASAN Medical Center (AMC) for clinical development services market in Asia.

The alliance offers regional and international sponsors with access to quality clinical trial services throughout Asia, with a focus on early phase development.

"Through our collaboration with AMC we look forward to helping our clients take advantage of opportunities to support their Korea-based development and commercialization programs to benefit patients in Korea, throughout Asia, and around the world," said Mark A. Goldberg, M.D., chief operating officer, PAREXEL International.